Melissa Alsina Selected Research

Melissa Alsina Research Topics

Disease

67	Multiple Myeloma 12/2023 - 06/2003
15	Neoplasms (Cancer) 12/2023 - 05/2004
10	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 07/2010
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2017 - 07/2006
4	Plasma Cell Leukemia 10/2023 - 12/2011
4	Infections 12/2022 - 01/2012
4	Bronchiolitis Obliterans Syndrome 11/2022 - 12/2012
4	Hematologic Neoplasms (Hematological Malignancy) 09/2012 - 04/2004
3	Disease Progression 01/2022 - 07/2009
2	Cytokine Release Syndrome 10/2023 - 01/2012
2	Cytopenia 09/2023 - 12/2022
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2011
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018 - 10/2012
2	Fanconi Anemia (Fanconi's Anemia) 12/2009 - 11/2003
1	Ventricular Tachycardia 01/2023
1	Atrial Fibrillation 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Heart Failure 01/2023
1	Immunoglobulin Light-chain Amyloidosis 01/2022
1	Amyloidosis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Cardiotoxicity 01/2018
1	Paraproteinemias (Monoclonal Gammopathy) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Hypoalbuminemia 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Diarrhea 03/2017
1	Fatigue 03/2017
1	Thrombocytopenia (Thrombopenia) 03/2017
1	Pathologic Complete Response 03/2016
1	Renal Insufficiency (Renal Failure) 09/2013
1	Lymphoma (Lymphomas) 09/2012
1	Stroke (Strokes) 01/2012

Drug/Important Bio-Agent (IBA)

21	Bortezomib (Velcade)FDA Link 01/2022 - 06/2003
19	Lenalidomide (CC 5013)FDA Link 01/2022 - 11/2006
17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2007
8	idecabtagene vicleucelIBA 10/2023 - 12/2022
8	carfilzomibIBA 01/2021 - 06/2012
7	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 01/2023
7	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2023
7	Proteasome InhibitorsIBA 01/2018 - 03/2006
7	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 11/2003
6	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 07/2010
5	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 07/2010
4	B-Cell Maturation AntigenIBA 10/2023 - 01/2023
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2015
4	Sirolimus (Rapamycin)FDA Link 07/2015 - 09/2011
3	GlucocorticoidsIBA 11/2022 - 09/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 07/2010
3	PanobinostatIBA 03/2017 - 10/2013
3	tipifarnib (R115777)IBA 08/2005 - 05/2004
3	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2005 - 09/2003
2	VaccinesIBA 11/2023 - 09/2013
2	Ferritins (Ferritin)IBA 10/2023 - 10/2023
2	ofatumumab FDA Link 11/2022 - 06/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2017
2	Immunomodulating AgentsIBA 01/2018 - 10/2015
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 01/2014
2	Thalidomide (Thalomid)FDA Link 10/2015 - 07/2004
2	Rituximab (Mabthera)FDA Link 07/2013 - 08/2011
2	Busulfan (Busulfex)FDA Link 07/2013 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 12/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2012 - 11/2007
2	Narcotics (Narcotic Analgesics)IBA 01/2012 - 07/2010
2	tanespimycin (17AAG)IBA 06/2011 - 08/2010
1	AlbuminsIBA 12/2023
1	SurvivinIBA 11/2023
1	C-Reactive ProteinIBA 10/2023
1	ixazomibIBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2022
1	IgKIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 10/2015
1	Etoposide (VP 16)FDA LinkGeneric 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015
1	1-dodecylpyridoxal (PLD)IBA 01/2014
1	AntigensIBA 09/2013
1	pomalidomideIBA 03/2013
1	Midazolam (Versed)FDA LinkGeneric 01/2013
1	Cytochrome P-450 CYP3AIBA 01/2013
1	perifosineIBA 08/2012
1	Immunoglobulin G (IgG)IBA 01/2012

Therapy/Procedure

29	Therapeutics 12/2023 - 11/2005
10	Cell Transplantation 01/2023 - 08/2011
8	Drug Therapy (Chemotherapy) 01/2017 - 06/2003
5	Transplantation 01/2022 - 07/2008
4	Homologous Transplantation 01/2023 - 10/2011
3	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2011
2	Immunotherapy 05/2024 - 09/2013
2	Stem Cell Transplantation 01/2022 - 07/2004
2	Salvage Therapy 01/2013 - 10/2012
2	Drug Tapering 09/2011 - 07/2006
1	Aftercare (After-Treatment) 01/2023
1	Length of Stay 01/2023
1	Immunomodulation 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2013